Statistical Excellence in the Pharmaceutical Industry Award

We are now accepting entries for the 2020 Award

Our award for statistical excellence in the pharmaceutical industry is made jointly with the RSS (Royal Statistical Society) every year. The award is for the most influential example of the application of an existing statistical practice, or the implementation of an innovative statistical practice, in this industry.

Criteria

We are looking for entries that have demonstrated one or more of the following:

  • A clear understanding of the needs of researchers and investigators
  • An application of an existing statistical practice to a new area that has increased the quality and efficiency of investigations
  • A new development in the design of investigations and/or the analysis of data that has led to further insights into the safety, efficacy and value of medicines or devices
  • An excellent way to communicate results that is clear and helpful to a wide array of users, showing how statisticians understand the range of user needs

Nominees can be based anywhere in the world and do not need to be a member of PSI or the RSS. The award will be presented at the Annual PSI Conference which will be held in Barcelona from 7th – 10th June 2020. 

Download the entry form here.

The deadline for entries is midnight on Monday 13th April 2020.

Previous Winners

The 2019 award was jointly presented to Mike Smith (Pfizer) for “Improving the quality and reliability of animal research through the use of InVivoStat: a statistical software package for animal researchers” and Dr Graeme Archer & Jacquie Christie (GSK) for “Enhancing drug development using clinically interpretable treatment effect measures (‘estimands‘) that allow for efficient statistical analyses”. 

The 2018 award was jointly presented to Dr. Mouna Akacha (Novartis) for “Enhancing drug development using clinically interpretable treatment effect measures (‘estimands‘) that allow for efficient statistical analyses” and Dr. Simon Bate for “Improving the quality and reliability of animal research through the use of InVivoStat: a statistical software package for animal researchers”. 

The 2017 award was presented to Michael O'Kelly for his work 'Promoting analytical solutions and best practices for handling missing data in pharmaceutical industry'.  The judges felt that in this respect, he has made a major contribution to enhancing the practical application of modelling and simulation methodology and tools for analysing data with missing values. 
Richard Nixon of Novartis was presented with the award in 2016 for “Enhancing decision-making in drug development using quantitative approaches’. 

Katrina Gore and Nicky Best (joint winners, 2015, Pfizer and GSK respectively). Katrina Gore for her work on the Assay Capability Tool (ACT), designed to guide the development of drug discovery assays. Nicky Best for her work implementing a process that has turned beliefs about the chances of success into formal prior distributions.

Award cropped

Upcoming Events

Visualising the drug harm profile in Randomised Controlled Trials – A Consensus of UK trial researchers

The UKCRC CTU statisticians’ operations group in collaboration with Imperial College London are hosting a one-day consensus meeting to develop recommendations to support researchers in their choice of visualisations for adverse event data in RCT publications.

PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?

Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.

Introduction To Industry Training Course 2020

The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies from October 2020 to July 2021 to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 - 4 sessions in the UK. It promises to be a truly memorable course.

A PSI Training Course - R for SAS Users

This course is aimed at Statisticians and Programmers experienced in SAS, but little or no experience with R. An Introduction to R studio and the R language, statistical graphics, programming statistical models, simulations and more…

PSI Toxicology SIG Workshop

PSI Toxicology SIG workshop – 24th and 25th November 2020 The Toxicology SIG provides a forum for statisticians working in regulatory/investigative toxicology, as well as most other pre-clinical areas, to discuss issues and interact with one another. This 1.5-day workshop will involve approximately 20 statisticians, focusing on discussions around “best practice” in the statistical analysis of various data types. The afternoon of Day 1 will include a 4.5 hour Bayesian training course focused towards applications in toxicology/pre-clinical, provided by Prof. Dr. Katja Ickstadt and is included in the workshop fee. The cost will be £270 including VAT per delegate, inclusive of food and one night’s accommodation (and the training course). The workshop is being held at the Crowne Plaza Hotel, Heathrow. The agenda and topics that will be discussed are yet to be finalised, but please get in touch with gareth.thomas@covance.com if you have suggestions. Full details will be circulated in the coming weeks.

Latest Jobs

Principal / Senior Principal Biostatisticians (Phases II-IV & Statistical Analysis Research Centre)

Covance are currently recruiting for 3 Principal / Senior Principal Biostatisticians in two different departments.

Statistical Director for Health Technology Assessment in Biostatistics

Global pharma company Novo Nordisk are right now looking for a Statistical Director to drive the Health Technology Assessment agenda in the Biostatistical Centre of Expertise in their office just outside Copenhagen.

Statisticians and Statistical Programmers – Senior/Principal/Associate Director/Director - Oncology / Respiratory / CVRM – Early and Late Phase

Would you like to be a part of a Statistical and Programming group, who have direct strategic impact on drug development, playing a key role in getting medicines to patients?